Pctr1 and Pctr2 have been mapped as loci for susceptibility to pristine induced plasmacytoma [25,26], and Cdkn2a has been suggested to be a corresponding gene for Pctr1[27,28]. The gene discussed is CDKN2A; the disease is plasmacytoma.